Land: Ierland
Taal: Engels
Bron: HPRA (Health Products Regulatory Authority)
TELMISARTAN
Laboratorios LICONSA, S.A.
TELMISARTAN
40 Milligram
Tablets
Product subject to prescription which may be renewed (B)
Withdrawn
2014-06-13
1 PACKAGE LEAFLET: INFORMATION FOR THE USER20 MG TABLETS Lees het volledige document40 MG TABLETS 80 MG TABLETS Telmisartan READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What 20/40/80 mg tablets are and what they are used for 2. Before you take 20/40/80 mg tablets 3. How to take 20/40/80 mg tablets 4. Possible side effects 5. How to store 20/40/80 mg tablets 6. Further information 1. WHAT 20/40/80 MG TABLETS ARE AND WHAT THEY ARE USED FOR belongs to a class of medicines known as angiotensin II receptor antagonists. Angiotensin II is a substance produced in your body which causes your blood vessels to narrow, thus increasing your blood pressure. blocks the effect of angiotensin II so that the blood vessels relax, and your blood pressure is lowered. IS USED TO treat essential hypertension (high blood pressure). ‘Essential’ means that the high blood pressure is not caused by any other condition. High blood pressure, if not treated, can damage blood vessels in several organs, which could lead sometimes to heart attack, heart or kidney failure, stroke, or blindness. There are usually no symptoms of high blood pressure before damage occurs. Thus it is important
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zanacodar 40mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 40 mg of telmisartan. For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet White or slightly yellowish, oblong tablets 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypertension: Treatment of essential hypertension in adults Cardiovascular prevention: Reduction of cardiovascular morbidity in patients with: i) manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease) or ii) type 2 diabetes mellitus with documented target organ damage. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Treatment of essential hypertension: The usually effective dose is 40 mg once daily. Some patients may already benefit at a daily dose of 20 mg. In cases where the target blood pressure is not achieved, telmisartan dose can be increased to a maximum of 80 mg once daily. Alternatively, telmisartan may be used in combination with thiazidetype diuretics such as hydrochlorothiazide which has been shown to have an additive blood pressure lowering effect with telmisartan. When considering raising the dose, it must be borne in mind that the maximum antihypertensive effect is generally attained four to eight weeks after the start of treatment (see section 5.1). Cardiovascular prevention: The recommended dose is 80 mg once daily. It is known whether doses lower than 80 mg of telmisartan are effective in reducing cardiovascular morbidity. When initiating telmisartan therapy for the reduction of cardiovascular mobidity, close monitoring of blood pressure is recommended, and if appropriate adjustment of medications that lower blood pressure may be necessary. Zanacodar may be taken Lees het volledige document